Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Depression
- Traumatology
- Hypertension
- Obstetrics and Gynecology
- Forensic and Legal Medicine
- Chronic Disease
- Preventive Medicine
- Gerontology
Abstract
Citation: Clin Case Rep Int. 2023;7(1):1455.DOI: 10.25107/2638-4558.1455
Anaphylactic Reaction to Parenteral Artesunate
Mohit C, Sekhar Paul S, Meena CP and Ajmal Z
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
Vinayaka Missions Kirupananda Variyar Medical College, Salem, India
*Correspondance to: Mohit Chowdhury
PDF Full Text Case Report | Open Access
Abstract:
Severe malaria is a medical emergency requiring prompt diagnosis and treatment. For the treatment of severe malaria, WHO recommends artesunate above quinine. An 18-year-old male presented to a tertiary care hospital in India with severe and COVID-19 co-infection. Intravenous artesunate was administered to the patient for prompt management, following which he had an anaphylactic reaction in the form of sudden onset generalized erythematous maculo-papular blanchable urticarial rash, tachypnea & tachycardia immediately after drug administration. The drug-induced anaphylaxis was managed with 0.5 ml intramuscular adrenaline (1:1000) & 100 mg intravenous hydrocortisone. After 7 days of the adverse reaction, a positive intradermal skin test confirmed the diagnosis of artesunate-induced hypersensitivity. Anaphylaxis to parenteral artesunate is a sparce occurrence with limited data available. Whether co-infection with SARS-CoV-2 causes any hypersusceptibility needs to be evaluated.
Keywords:
#
Cite the Article:
Mohit C, Sekhar Paul S, Meena CP, Ajmal Z. Anaphylactic Reaction to Parenteral Artesunate. Clin Case Rep Int. 2023; 7: 1455.